カテゴリ： 世界, 医療/バイオ, Market Monitor Global

筋肉内HPVワクチンのグローバル市場展望 2023年-2029年：2価、4価、9価

■ 英語タイトル：Intramuscular HPV Vaccine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14375）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14375
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：118
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[筋肉内HPVワクチンのグローバル市場展望 2023年-2029年：2価、4価、9価]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の筋肉内HPVワクチン市場規模と予測を収録しています。・世界の筋肉内HPVワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の筋肉内HPVワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の筋肉内HPVワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「2価」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

筋肉内HPVワクチンのグローバル主要企業は、Merck Sharp & Dohme (MSD)、 Pfizer、 Sanofi、 GSK、 Serum Institute、 Astellas Pharma、 CSL、 Emergent BioSolutions、 GlaxoSmithKline、 Johnson & Johnson、 MedImmune、 Walvax Biotechnology、 Liaoning Chengda Biotechnology、 Hualan Biological Engineering、 Sinovac Biotech、 Chongqing Zhifei Biological Products、 Chang Chun High and New Technology Industries (Group)、 Beijing Wantai Biological Pharmacy Enterprise、 Jiangsu Recbio Technologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、筋肉内HPVワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の筋肉内HPVワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の筋肉内HPVワクチン市場：タイプ別市場シェア、2022年
・2価、4価、9価

世界の筋肉内HPVワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の筋肉内HPVワクチン市場：用途別市場シェア、2022年
・男性、女性

世界の筋肉内HPVワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の筋肉内HPVワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における筋肉内HPVワクチンのグローバル売上、2018年-2023年
・主要企業における筋肉内HPVワクチンのグローバル売上シェア、2022年
・主要企業における筋肉内HPVワクチンのグローバル販売量、2018年-2023年
・主要企業における筋肉内HPVワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck Sharp & Dohme (MSD)、 Pfizer、 Sanofi、 GSK、 Serum Institute、 Astellas Pharma、 CSL、 Emergent BioSolutions、 GlaxoSmithKline、 Johnson & Johnson、 MedImmune、 Walvax Biotechnology、 Liaoning Chengda Biotechnology、 Hualan Biological Engineering、 Sinovac Biotech、 Chongqing Zhifei Biological Products、 Chang Chun High and New Technology Industries (Group)、 Beijing Wantai Biological Pharmacy Enterprise、 Jiangsu Recbio Technology

*************************************************************

・調査・分析レポートの概要
筋肉内HPVワクチン市場の定義
市場セグメント
世界の筋肉内HPVワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の筋肉内HPVワクチン市場規模
世界の筋肉内HPVワクチン市場規模：2022年 VS 2029年
世界の筋肉内HPVワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの筋肉内HPVワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の筋肉内HPVワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：2価、4価、9価
筋肉内HPVワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：男性、女性
筋肉内HPVワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別筋肉内HPVワクチン市場規模 2022年と2029年
地域別筋肉内HPVワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck Sharp & Dohme (MSD)、 Pfizer、 Sanofi、 GSK、 Serum Institute、 Astellas Pharma、 CSL、 Emergent BioSolutions、 GlaxoSmithKline、 Johnson & Johnson、 MedImmune、 Walvax Biotechnology、 Liaoning Chengda Biotechnology、 Hualan Biological Engineering、 Sinovac Biotech、 Chongqing Zhifei Biological Products、 Chang Chun High and New Technology Industries (Group)、 Beijing Wantai Biological Pharmacy Enterprise、 Jiangsu Recbio Technology
...

This research report provides a comprehensive analysis of the Intramuscular HPV Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Intramuscular HPV Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Intramuscular HPV Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Intramuscular HPV Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Intramuscular HPV Vaccine market presents opportunities for various stakeholders, including Male, Female. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Intramuscular HPV Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Intramuscular HPV Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The characteristics and precautions of intramuscular injection of HPV vaccine include: recommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.
Key Features:
The research report on the Intramuscular HPV Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Intramuscular HPV Vaccine market.
Market Overview: The report provides a comprehensive overview of the Intramuscular HPV Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Bivalent, Quadrivalent), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Intramuscular HPV Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Intramuscular HPV Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Intramuscular HPV Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Intramuscular HPV Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Intramuscular HPV Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Intramuscular HPV Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Intramuscular HPV Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Intramuscular HPV Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Intramuscular HPV Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Bivalent
Quadrivalent
Nine-valent
Market segment by Application
Male
Female
Global Intramuscular HPV Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Merck Sharp & Dohme (MSD)
Pfizer
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
Sinovac Biotech
Chongqing Zhifei Biological Products
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intramuscular HPV Vaccine, market overview.
Chapter 2: Global Intramuscular HPV Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Intramuscular HPV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intramuscular HPV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intramuscular HPV Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Intramuscular HPV Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intramuscular HPV Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intramuscular HPV Vaccine Overall Market Size
2.1 Global Intramuscular HPV Vaccine Market Size: 2022 VS 2029
2.2 Global Intramuscular HPV Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Intramuscular HPV Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Intramuscular HPV Vaccine Players in Global Market
3.2 Top Global Intramuscular HPV Vaccine Companies Ranked by Revenue
3.3 Global Intramuscular HPV Vaccine Revenue by Companies
3.4 Global Intramuscular HPV Vaccine Sales by Companies
3.5 Global Intramuscular HPV Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Intramuscular HPV Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Intramuscular HPV Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intramuscular HPV Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Intramuscular HPV Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Intramuscular HPV Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Intramuscular HPV Vaccine Market Size Markets, 2022 & 2029
4.1.2 Bivalent
4.1.3 Quadrivalent
4.1.4 Nine-valent
4.2 By Type – Global Intramuscular HPV Vaccine Revenue & Forecasts
4.2.1 By Type – Global Intramuscular HPV Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Intramuscular HPV Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Intramuscular HPV Vaccine Sales & Forecasts
4.3.1 By Type – Global Intramuscular HPV Vaccine Sales, 2018-2023
4.3.2 By Type – Global Intramuscular HPV Vaccine Sales, 2024-2029
4.3.3 By Type – Global Intramuscular HPV Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Intramuscular HPV Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Intramuscular HPV Vaccine Market Size, 2022 & 2029
5.1.2 Male
5.1.3 Female
5.2 By Application – Global Intramuscular HPV Vaccine Revenue & Forecasts
5.2.1 By Application – Global Intramuscular HPV Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Intramuscular HPV Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Intramuscular HPV Vaccine Sales & Forecasts
5.3.1 By Application – Global Intramuscular HPV Vaccine Sales, 2018-2023
5.3.2 By Application – Global Intramuscular HPV Vaccine Sales, 2024-2029
5.3.3 By Application – Global Intramuscular HPV Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Intramuscular HPV Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Intramuscular HPV Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Intramuscular HPV Vaccine Revenue & Forecasts
6.2.1 By Region – Global Intramuscular HPV Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Intramuscular HPV Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Intramuscular HPV Vaccine Sales & Forecasts
6.3.1 By Region – Global Intramuscular HPV Vaccine Sales, 2018-2023
6.3.2 By Region – Global Intramuscular HPV Vaccine Sales, 2024-2029
6.3.3 By Region – Global Intramuscular HPV Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Intramuscular HPV Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Intramuscular HPV Vaccine Sales, 2018-2029
6.4.3 US Intramuscular HPV Vaccine Market Size, 2018-2029
6.4.4 Canada Intramuscular HPV Vaccine Market Size, 2018-2029
6.4.5 Mexico Intramuscular HPV Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Intramuscular HPV Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Intramuscular HPV Vaccine Sales, 2018-2029
6.5.3 Germany Intramuscular HPV Vaccine Market Size, 2018-2029
6.5.4 France Intramuscular HPV Vaccine Market Size, 2018-2029
6.5.5 U.K. Intramuscular HPV Vaccine Market Size, 2018-2029
6.5.6 Italy Intramuscular HPV Vaccine Market Size, 2018-2029
6.5.7 Russia Intramuscular HPV Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Intramuscular HPV Vaccine Market Size, 2018-2029
6.5.9 Benelux Intramuscular HPV Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Intramuscular HPV Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Intramuscular HPV Vaccine Sales, 2018-2029
6.6.3 China Intramuscular HPV Vaccine Market Size, 2018-2029
6.6.4 Japan Intramuscular HPV Vaccine Market Size, 2018-2029
6.6.5 South Korea Intramuscular HPV Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Intramuscular HPV Vaccine Market Size, 2018-2029
6.6.7 India Intramuscular HPV Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Intramuscular HPV Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Intramuscular HPV Vaccine Sales, 2018-2029
6.7.3 Brazil Intramuscular HPV Vaccine Market Size, 2018-2029
6.7.4 Argentina Intramuscular HPV Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Intramuscular HPV Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Intramuscular HPV Vaccine Sales, 2018-2029
6.8.3 Turkey Intramuscular HPV Vaccine Market Size, 2018-2029
6.8.4 Israel Intramuscular HPV Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Intramuscular HPV Vaccine Market Size, 2018-2029
6.8.6 UAE Intramuscular HPV Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck Sharp & Dohme (MSD)
7.1.1 Merck Sharp & Dohme (MSD) Company Summary
7.1.2 Merck Sharp & Dohme (MSD) Business Overview
7.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Major Product Offerings
7.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Sharp & Dohme (MSD) Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Intramuscular HPV Vaccine Major Product Offerings
7.2.4 Pfizer Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Intramuscular HPV Vaccine Major Product Offerings
7.3.4 Sanofi Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Intramuscular HPV Vaccine Major Product Offerings
7.4.4 GSK Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Serum Institute
7.5.1 Serum Institute Company Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Intramuscular HPV Vaccine Major Product Offerings
7.5.4 Serum Institute Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute Key News & Latest Developments
7.6 Astellas Pharma
7.6.1 Astellas Pharma Company Summary
7.6.2 Astellas Pharma Business Overview
7.6.3 Astellas Pharma Intramuscular HPV Vaccine Major Product Offerings
7.6.4 Astellas Pharma Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Astellas Pharma Key News & Latest Developments
7.7 CSL
7.7.1 CSL Company Summary
7.7.2 CSL Business Overview
7.7.3 CSL Intramuscular HPV Vaccine Major Product Offerings
7.7.4 CSL Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 CSL Key News & Latest Developments
7.8 Emergent BioSolutions
7.8.1 Emergent BioSolutions Company Summary
7.8.2 Emergent BioSolutions Business Overview
7.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Major Product Offerings
7.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Emergent BioSolutions Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Major Product Offerings
7.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Intramuscular HPV Vaccine Major Product Offerings
7.10.4 Johnson & Johnson Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 MedImmune
7.11.1 MedImmune Company Summary
7.11.2 MedImmune Business Overview
7.11.3 MedImmune Intramuscular HPV Vaccine Major Product Offerings
7.11.4 MedImmune Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 MedImmune Key News & Latest Developments
7.12 Walvax Biotechnology
7.12.1 Walvax Biotechnology Company Summary
7.12.2 Walvax Biotechnology Business Overview
7.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Major Product Offerings
7.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Walvax Biotechnology Key News & Latest Developments
7.13 Liaoning Chengda Biotechnology
7.13.1 Liaoning Chengda Biotechnology Company Summary
7.13.2 Liaoning Chengda Biotechnology Business Overview
7.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Major Product Offerings
7.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Liaoning Chengda Biotechnology Key News & Latest Developments
7.14 Hualan Biological Engineering
7.14.1 Hualan Biological Engineering Company Summary
7.14.2 Hualan Biological Engineering Business Overview
7.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Major Product Offerings
7.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Hualan Biological Engineering Key News & Latest Developments
7.15 Sinovac Biotech
7.15.1 Sinovac Biotech Company Summary
7.15.2 Sinovac Biotech Business Overview
7.15.3 Sinovac Biotech Intramuscular HPV Vaccine Major Product Offerings
7.15.4 Sinovac Biotech Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Sinovac Biotech Key News & Latest Developments
7.16 Chongqing Zhifei Biological Products
7.16.1 Chongqing Zhifei Biological Products Company Summary
7.16.2 Chongqing Zhifei Biological Products Business Overview
7.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Major Product Offerings
7.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Chongqing Zhifei Biological Products Key News & Latest Developments
7.17 Chang Chun High and New Technology Industries (Group)
7.17.1 Chang Chun High and New Technology Industries (Group) Company Summary
7.17.2 Chang Chun High and New Technology Industries (Group) Business Overview
7.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Major Product Offerings
7.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Chang Chun High and New Technology Industries (Group) Key News & Latest Developments
7.18 Beijing Wantai Biological Pharmacy Enterprise
7.18.1 Beijing Wantai Biological Pharmacy Enterprise Company Summary
7.18.2 Beijing Wantai Biological Pharmacy Enterprise Business Overview
7.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Major Product Offerings
7.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Beijing Wantai Biological Pharmacy Enterprise Key News & Latest Developments
7.19 Jiangsu Recbio Technology
7.19.1 Jiangsu Recbio Technology Company Summary
7.19.2 Jiangsu Recbio Technology Business Overview
7.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Major Product Offerings
7.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 Jiangsu Recbio Technology Key News & Latest Developments
8 Global Intramuscular HPV Vaccine Production Capacity, Analysis
8.1 Global Intramuscular HPV Vaccine Production Capacity, 2018-2029
8.2 Intramuscular HPV Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Intramuscular HPV Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intramuscular HPV Vaccine Supply Chain Analysis
10.1 Intramuscular HPV Vaccine Industry Value Chain
10.2 Intramuscular HPV Vaccine Upstream Market
10.3 Intramuscular HPV Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intramuscular HPV Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Intramuscular HPV Vaccine in Global Market
Table 2. Top Intramuscular HPV Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Intramuscular HPV Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Intramuscular HPV Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Intramuscular HPV Vaccine Sales by Companies, (Units), 2018-2023
Table 6. Global Intramuscular HPV Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Intramuscular HPV Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Intramuscular HPV Vaccine Product Type
Table 9. List of Global Tier 1 Intramuscular HPV Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intramuscular HPV Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Intramuscular HPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Intramuscular HPV Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Intramuscular HPV Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Intramuscular HPV Vaccine Sales (Units), 2018-2023
Table 15. By Type - Global Intramuscular HPV Vaccine Sales (Units), 2024-2029
Table 16. By Application – Global Intramuscular HPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Intramuscular HPV Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Intramuscular HPV Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Intramuscular HPV Vaccine Sales (Units), 2018-2023
Table 20. By Application - Global Intramuscular HPV Vaccine Sales (Units), 2024-2029
Table 21. By Region – Global Intramuscular HPV Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Intramuscular HPV Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Intramuscular HPV Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Intramuscular HPV Vaccine Sales (Units), 2018-2023
Table 25. By Region - Global Intramuscular HPV Vaccine Sales (Units), 2024-2029
Table 26. By Country - North America Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Intramuscular HPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Intramuscular HPV Vaccine Sales, (Units), 2018-2023
Table 29. By Country - North America Intramuscular HPV Vaccine Sales, (Units), 2024-2029
Table 30. By Country - Europe Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Intramuscular HPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Intramuscular HPV Vaccine Sales, (Units), 2018-2023
Table 33. By Country - Europe Intramuscular HPV Vaccine Sales, (Units), 2024-2029
Table 34. By Region - Asia Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Intramuscular HPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Intramuscular HPV Vaccine Sales, (Units), 2018-2023
Table 37. By Region - Asia Intramuscular HPV Vaccine Sales, (Units), 2024-2029
Table 38. By Country - South America Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Intramuscular HPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Intramuscular HPV Vaccine Sales, (Units), 2018-2023
Table 41. By Country - South America Intramuscular HPV Vaccine Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Intramuscular HPV Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Intramuscular HPV Vaccine Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Intramuscular HPV Vaccine Sales, (Units), 2024-2029
Table 46. Merck Sharp & Dohme (MSD) Company Summary
Table 47. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product Offerings
Table 48. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Sharp & Dohme (MSD) Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Intramuscular HPV Vaccine Product Offerings
Table 52. Pfizer Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Intramuscular HPV Vaccine Product Offerings
Table 56. Sanofi Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. GSK Company Summary
Table 59. GSK Intramuscular HPV Vaccine Product Offerings
Table 60. GSK Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. GSK Key News & Latest Developments
Table 62. Serum Institute Company Summary
Table 63. Serum Institute Intramuscular HPV Vaccine Product Offerings
Table 64. Serum Institute Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Serum Institute Key News & Latest Developments
Table 66. Astellas Pharma Company Summary
Table 67. Astellas Pharma Intramuscular HPV Vaccine Product Offerings
Table 68. Astellas Pharma Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Astellas Pharma Key News & Latest Developments
Table 70. CSL Company Summary
Table 71. CSL Intramuscular HPV Vaccine Product Offerings
Table 72. CSL Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. CSL Key News & Latest Developments
Table 74. Emergent BioSolutions Company Summary
Table 75. Emergent BioSolutions Intramuscular HPV Vaccine Product Offerings
Table 76. Emergent BioSolutions Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Emergent BioSolutions Key News & Latest Developments
Table 78. GlaxoSmithKline Company Summary
Table 79. GlaxoSmithKline Intramuscular HPV Vaccine Product Offerings
Table 80. GlaxoSmithKline Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. GlaxoSmithKline Key News & Latest Developments
Table 82. Johnson & Johnson Company Summary
Table 83. Johnson & Johnson Intramuscular HPV Vaccine Product Offerings
Table 84. Johnson & Johnson Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Johnson & Johnson Key News & Latest Developments
Table 86. MedImmune Company Summary
Table 87. MedImmune Intramuscular HPV Vaccine Product Offerings
Table 88. MedImmune Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. MedImmune Key News & Latest Developments
Table 90. Walvax Biotechnology Company Summary
Table 91. Walvax Biotechnology Intramuscular HPV Vaccine Product Offerings
Table 92. Walvax Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Walvax Biotechnology Key News & Latest Developments
Table 94. Liaoning Chengda Biotechnology Company Summary
Table 95. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product Offerings
Table 96. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Liaoning Chengda Biotechnology Key News & Latest Developments
Table 98. Hualan Biological Engineering Company Summary
Table 99. Hualan Biological Engineering Intramuscular HPV Vaccine Product Offerings
Table 100. Hualan Biological Engineering Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Hualan Biological Engineering Key News & Latest Developments
Table 102. Sinovac Biotech Company Summary
Table 103. Sinovac Biotech Intramuscular HPV Vaccine Product Offerings
Table 104. Sinovac Biotech Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Sinovac Biotech Key News & Latest Developments
Table 106. Chongqing Zhifei Biological Products Company Summary
Table 107. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product Offerings
Table 108. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Chongqing Zhifei Biological Products Key News & Latest Developments
Table 110. Chang Chun High and New Technology Industries (Group) Company Summary
Table 111. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product Offerings
Table 112. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Chang Chun High and New Technology Industries (Group) Key News & Latest Developments
Table 114. Beijing Wantai Biological Pharmacy Enterprise Company Summary
Table 115. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product Offerings
Table 116. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Beijing Wantai Biological Pharmacy Enterprise Key News & Latest Developments
Table 118. Jiangsu Recbio Technology Company Summary
Table 119. Jiangsu Recbio Technology Intramuscular HPV Vaccine Product Offerings
Table 120. Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Jiangsu Recbio Technology Key News & Latest Developments
Table 122. Intramuscular HPV Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 123. Global Intramuscular HPV Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Intramuscular HPV Vaccine Production by Region, 2018-2023 (Units)
Table 125. Global Intramuscular HPV Vaccine Production by Region, 2024-2029 (Units)
Table 126. Intramuscular HPV Vaccine Market Opportunities & Trends in Global Market
Table 127. Intramuscular HPV Vaccine Market Drivers in Global Market
Table 128. Intramuscular HPV Vaccine Market Restraints in Global Market
Table 129. Intramuscular HPV Vaccine Raw Materials
Table 130. Intramuscular HPV Vaccine Raw Materials Suppliers in Global Market
Table 131. Typical Intramuscular HPV Vaccine Downstream
Table 132. Intramuscular HPV Vaccine Downstream Clients in Global Market
Table 133. Intramuscular HPV Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Intramuscular HPV Vaccine Segment by Type in 2022
Figure 2. Intramuscular HPV Vaccine Segment by Application in 2022
Figure 3. Global Intramuscular HPV Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Intramuscular HPV Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Intramuscular HPV Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Intramuscular HPV Vaccine Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Intramuscular HPV Vaccine Revenue in 2022
Figure 9. By Type - Global Intramuscular HPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Intramuscular HPV Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Intramuscular HPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Intramuscular HPV Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Intramuscular HPV Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Intramuscular HPV Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 23. US Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 37. China Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Intramuscular HPV Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Intramuscular HPV Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Intramuscular HPV Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Intramuscular HPV Vaccine Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Intramuscular HPV Vaccine by Region, 2022 VS 2029
Figure 54. Intramuscular HPV Vaccine Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 筋肉内薬物送達装置のグローバル市場展望 2023年-2029年：分子構造、ポリマー、ゲル、その他
  • インフルエンザワクチンのグローバル市場展望 2023年-2029年：3価インフルエンザワクチン、4価インフルエンザワクチン
  • 卵不使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：細胞培養インフルエンザワクチン、組換えインフルエンザワクチン
  • 小児用インフルエンザワクチンのグローバル市場展望 2023年-2029年：点鼻薬、注射
  • IPVワクチンのグローバル市場展望 2023年-2029年：Mahoney株、MEF1株、Saukett株
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14375 )"筋肉内HPVワクチンのグローバル市場展望 2023年-2029年：2価、4価、9価" (英文：Intramuscular HPV Vaccine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。